$175.92
19.0712.16%
Last update: Nov 6, 4:00 PM
Palvella Therapeutics Inc
PVLANASDAQ
Palvella Therapeutics (PVLA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.72 | $-1.16 | $-0.92 | $-0.93 |
| Actual | $-1.70 | $-1.52 | $-1.20 | $-1.08 |
| Surprise | +1.16% | -31.0% | -30.4% | -16.1% |
| Revenue | ||||
| Estimate | $40000 | — | — | — |
| Actual | $0 | $0 | — | $0 |
| Surprise | -100.0% | — | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.81 | $-2.17 | $-2.26 | $-2.74 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $-1.70 | $-1.72 | 1.16 % |
| Q2 | Aug 4, 2026 | $-1.52 | $-1.16 | -31.0 % |
| Q1 | May 7, 2026 | $-1.20 | $-0.92 | -30.4 % |
| Q4 | Mar 31, 2026 | $-1.08 | $-0.93 | -16.1 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $0 | $40.00K | -100.0 % |
